` GENI (Genincode PLC) vs FTSE All Share Index Comparison - Alpha Spread

G
GENI
vs
F
FTSE All Share Index

Over the past 12 months, GENI has outperformed FTSE All Share Index, delivering a return of -74% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
GENI vs FTSE All Share Index

Loading
GENI
FTSE All Share Index
Add Stock

Performance Gap
GENI vs FTSE All Share Index

Loading
GENI
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
GENI vs FTSE All Share Index

Loading
GENI
FTSE All Share Index
Add Stock

Competitors Performance
Genincode PLC vs Peers

FTSE All Share Index
GENI
CVS
CGN
CI
FME
Add Stock

Genincode PLC
Glance View

Market Cap
4.6m GBX
Industry
Health Care

GENinCode UK Ltd. engages in the risk assessment and prediction of cardiovascular disease. The company is headquartered in Oxford, Oxfordshire. The company went IPO on 2021-07-22. The firm develops patented deoxyribonucleic acid (DNA) risk assessment products which utilize artificial intelligence (AI), bioinformatics and a globally recognized clinical evidence base to provide predictive analysis of a patient’s health risk. The Company’s clinical diagnostic tests cover global disease areas such as cardiovascular, cancer and diabetes.

GENI Intrinsic Value
3.18 GBX
Undervaluation 50%
Intrinsic Value
Price
G
Back to Top